(NBIX) Neurocrine Biosciences complete technical analysis [charts+indicators] | Buy/Sell Neurocrine Biosciences | (NBIX) share price targets
Complete technical analysis of Neurocrine Biosciences (NBIX) by charts plus indicators, forecast predictions and share price targets for Neurocrine Biosciences (NBIX)
Neurocrine Biosciences trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-30 View latest technical analysis
10 day averaged volume of Neurocrine Biosciences is 1209180
| Date | Daily Closing Price | Open | High | Low | Volume |
| 30 Fri Aug 2024 | 127.06 | 128.01 | 129.68 | 123.84 | 0.999 times |
| 30 Fri Aug 2024 | 127.06 | 128.01 | 129.68 | 123.84 | 1.023 times |
| 29 Thu Aug 2024 | 128.43 | 125.19 | 129.50 | 125.01 | 1.455 times |
| 28 Wed Aug 2024 | 123.76 | 125.90 | 128.00 | 119.76 | 3.993 times |
| 27 Tue Aug 2024 | 152.55 | 152.50 | 152.68 | 150.20 | 0.316 times |
| 26 Mon Aug 2024 | 152.27 | 153.13 | 154.00 | 151.70 | 0.406 times |
| 23 Fri Aug 2024 | 152.81 | 153.00 | 154.87 | 151.71 | 0.436 times |
| 22 Thu Aug 2024 | 152.57 | 151.61 | 153.42 | 151.17 | 0.534 times |
| 21 Wed Aug 2024 | 150.89 | 150.00 | 151.98 | 149.04 | 0.565 times |
| 20 Tue Aug 2024 | 149.59 | 147.30 | 149.92 | 145.54 | 0.544 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 124, for a target of 135.1 or 144.33
Share price targets for Neurocrine Biosciences (NBIX)
| Target Type | Value |
| Downside Target | 119.76 |
| Downside Target | 123.84 |
| Upside Target | 129.33 |
| Upside Target | 135.85 |
| Upside Target | 141.49 |
| Upside Target | 145.78 |
| Upside Target | 150.39 |
| Upside Target | 151.41 |
| Upside Target | 151.57 |
| Upside Target | 154.00 |
| Upside Target | 154.87 |
| Upside Target | 157.98 |
Intraday share price targets for Neurocrine Biosciences (NBIX)
| Target Type | Value |
| Downside Intraday Target | 124.04 |
| Downside Intraday Target | 121.02 |
| Upside Intraday Target | 129.88 |
| Upside Intraday Target | 132.7 |
| Downside Intraday Target | 126.86 |
Weekly technical analysis of Neurocrine Biosciences (NBIX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 30 Fri Aug 2024 | 127.06 | 128.01 | 129.68 | 123.84 | 0.139 times |
| 30 Fri Aug 2024 | 127.06 | 153.13 | 154.00 | 119.76 | 2.561 times |
| 23 Fri Aug 2024 | 152.81 | 145.01 | 154.87 | 144.61 | 1.043 times |
| 16 Fri Aug 2024 | 145.01 | 147.04 | 151.41 | 144.62 | 0.831 times |
| 09 Fri Aug 2024 | 147.32 | 149.31 | 151.57 | 143.65 | 0.599 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Neurocrine Biosciences (NBIX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 30 Fri Aug 2024 | 127.06 | 150.23 | 157.98 | 119.76 | 1.46 times |
| 31 Wed Jul 2024 | 141.57 | 138.11 | 150.39 | 135.85 | 0.912 times |
| 28 Fri Jun 2024 | 137.67 | 135.57 | 141.49 | 129.33 | 1.055 times |
| 31 Fri May 2024 | 135.41 | 140.18 | 145.78 | 131.90 | 0.977 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Neurocrine Biosciences (NBIX)
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Neurocrine Biosciences stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Neurocrine Biosciences in short term and the sell signal is strong.
Neurocrine Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Neurocrine Biosciences in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Neurocrine Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 132.67 and Neurocrine Biosciences (NBIX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Neurocrine Biosciences (NBIX) stock. Volume based technical analysis of Neurocrine Biosciences (NBIX) stock is negative.
Neurocrine Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Neurocrine Biosciences stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Neurocrine Biosciences in short term and the sell signal is strong.
Neurocrine Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Neurocrine Biosciences in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Neurocrine Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 132.67 and Neurocrine Biosciences (NBIX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Neurocrine Biosciences (NBIX) stock. Volume based technical analysis of Neurocrine Biosciences (NBIX) stock is negative.
Neurocrine Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.